Hantavirus

Jump to navigation Jump to search

Type chapter name here Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Type chapter name here from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hantavirus On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hantavirus

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hantavirus

CDC on Hantavirus

Hantavirus in the news

Blogs on Hantavirus

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Hantavirus

style="background:#Template:Taxobox colour;"|Hantavirus
Transmission electron micrograph of the Sin Nombre Hantavirus
Transmission electron micrograph of the Sin Nombre Hantavirus
style="background:#Template:Taxobox colour;" | Virus classification
Group: Group V ((-)ssRNA)
Family: Bunyaviridae
Genus: Hantavirus
Species

Andes virus (ANDV)
Bayou virus (BAYV)
Black Creek Canal virus (BCCV)
Cano Delgadito virus (CADV)
Choclo virus (CHOV)
Dobrava-Belgrade virus (DOBV)
Hantaan virus (HTNV)
Isla Vista virus (ISLAV)
Khabarovsk virus (KHAV)
Laguna Negra virus (LANV)
Muleshoe virus (MULV)
New York virus (NYV)
Prospect Hill virus (PHV)
Puumala virus (PUUV)
Rio Mamore virus (RIOMV)
Rio Segundo virus (RIOSV)
Seoul virus (SEOV)
Sin Nombre virus (SNV)
Thailand virus (THAIV)
Thottapalayam virus (TPMV)
Topografov virus (TOPV)
Tula virus (TULV)
Bakau virus

WikiDoc Resources for Hantavirus

Articles

Most recent articles on Hantavirus

Most cited articles on Hantavirus

Review articles on Hantavirus

Articles on Hantavirus in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Hantavirus

Images of Hantavirus

Photos of Hantavirus

Podcasts & MP3s on Hantavirus

Videos on Hantavirus

Evidence Based Medicine

Cochrane Collaboration on Hantavirus

Bandolier on Hantavirus

TRIP on Hantavirus

Clinical Trials

Ongoing Trials on Hantavirus at Clinical Trials.gov

Trial results on Hantavirus

Clinical Trials on Hantavirus at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Hantavirus

NICE Guidance on Hantavirus

NHS PRODIGY Guidance

FDA on Hantavirus

CDC on Hantavirus

Books

Books on Hantavirus

News

Hantavirus in the news

Be alerted to news on Hantavirus

News trends on Hantavirus

Commentary

Blogs on Hantavirus

Definitions

Definitions of Hantavirus

Patient Resources / Community

Patient resources on Hantavirus

Discussion groups on Hantavirus

Patient Handouts on Hantavirus

Directions to Hospitals Treating Hantavirus

Risk calculators and risk factors for Hantavirus

Healthcare Provider Resources

Symptoms of Hantavirus

Causes & Risk Factors for Hantavirus

Diagnostic studies for Hantavirus

Treatment of Hantavirus

Continuing Medical Education (CME)

CME Programs on Hantavirus

International

Hantavirus en Espanol

Hantavirus en Francais

Business

Hantavirus in the Marketplace

Patents on Hantavirus

Experimental / Informatics

List of terms related to Hantavirus


Overview

Hantaviruses belong to the bunyaviridae family of viruses. There are 5 genera within the bunyaviridae family: bunyavirus, phlebovirus, nairovirus, tospovirus, and hantavirus. Each is made up of negative-sensed, single-stranded RNA viruses. All these genera include arthropod-borne viruses, with the exception of hantavirus, which is a genus of rodent-borne agents.

The word hantavirus is derived from the Hantan River, where the Hantaan virus (the etiologic agent of Korean hemorrhagic fever) was first isolated by Dr. Lee Ho-Wang. The disease associated with Hantaan virus is called Korean hemorrhagic fever (a term that is no longer in use) or hemorrhagic fever with renal syndrome (HFRS), a term that is accepted by the World Health Organization.

.

Symptoms

Hemorrhagic Fever with Renal Syndrome (HFRS)

Hantavirus has an incubation time of 2-4 weeks in humans, before symptoms of infection occur. These symptoms can be split into five phases:

  • Hypotensive phase: This occurs when the blood platelet levels drop and symptoms can lead to tachycardia and hypoxemia. This phase can last for 2 days.
  • Oliguric phase: This phase lasts for 3-7 days and is characterised by the onset of renal failure and proteinuria occurs.
  • Diuretic phase: This is characterized by diuresis of 3-6L per day, which can last for a couple of days up to weeks.
  • Convalescent phase: This is normally when recovery occurs and symptoms begin to improve.

Hantavirus (Cardio-)Pulmonary Syndrome (HPS or HCPS)

Hantavirus pulmonary syndrome (HPS) is a deadly disease transmitted by infected rodents through urine, droppings, or saliva. Humans can contract the disease when they breathe in aerosolized virus. HPS was first recognized in 1993 and has since been identified throughout the United States. Although rare, HPS is potentially deadly. Rodent control in and around the home remains the primary strategy for preventing hantavirus infection.

These symptoms, which are very similar to HFRS, include tachycardia and tachypnoea. Such conditions can lead to a cardiopulmonary phase, where cardiovascular shock can occur, and hospitalization of the patient is required.

Treatment

  • Hanta virus treatment[1]
  • Supportive therapy
  • ICU management should include careful assessment, monitoring and adjustment of volume status and cardiac function, including inotropic and vasopressor support if needed.
  • Fluids should be administered carefully due to the potential for capillary leakage.
  • Supplemental oxygen should be administered if patients become hypoxic.
  • Equipment and materials for intubation and mechanical ventilation should be readily available since onset of respiratory failure may be precipitous.
  • Note (1): There is no specific treatment or cure for hantavirus infection.
  • Note (2): Treatment of patients with HPS remains supportive in nature.
  • Note (3): Patients should receive appropriate, broad-spectrum antibiotic therapy while awaiting confirmation of a diagnosis of HPS. Care during the initial stages of the disease should include antipyretics and analgesia as needed.
  • Note (4): If there is a high degree of suspicion of Hantavirus pulmonary syndrome, patients should be immediately transferred to an emergency department or intensive care unit (ICU) for close monitoring and care.
  • Note (5): if the individual is experiencing fever and fatigue and has a history of potential rural rodent exposure, together with shortness of breath, would be strongly suggestive of Hantavirus pulmonary syndrome.


External links

Template:WikiDoc Sources

References